• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN MFG DC BOULDER VALLEYLAB FT10; ELECTROSURGICAL, CUTTING & COAGULATION & ACCES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN MFG DC BOULDER VALLEYLAB FT10; ELECTROSURGICAL, CUTTING & COAGULATION & ACCES Back to Search Results
Model Number VLFT10GEN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Shock (2072); Loss of consciousness (2418); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 07/08/2022
Event Type  Death  
Manufacturer Narrative
Concomitant products: cryoflex surgical ablation probe, probe 60sf3 cryoflex 10-s 8l (serial# (b)(4)); cryoconsole, cardioblate, console r65cs1 cryoflex (serial# (b)(4)); clamp 49341 cardioblate lp ft (lot# 836c).(b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the reporter, the patient had shock.Vasopressor requirements was increased after extubation.The cardiac index was at 1.1 with worsening acidosis, acute kidney injury with elevated creatinine and uop less than 5 cc/hr, acute liver injury with elevated bilirubin, alt (alanine transaminase), ast (aspartate aminotransferase ), decreased level of consciousness and was subjected to be reintubated.Bicarb and fluids were given, tee (transesophageal echocardiogram) was unchanged from intra-op.And va ecmo (veno-arterial extracorporeal membrane oxygenation) was initiated.Following va ecmo, acidosis normalized, lactate was trending down, creatinine was trending down with increased uop, bilirubin remains elevated, alt/ast decreased, and the patient was sedated and vented.On (b)(6), uop was backed down and crrt (continuous renal replacement therapy) via ecmo circuit initiated.On (b)(6), the patient was sent to or for ecmo reconfiguration, but was unable to tolerate vv (veno-veno)and returned to va (veno-arterial).On (b)(6), the patient was sent to or for ecmo revision and converted to central ecmo.On (b)(6) 2022, ecmo was weaned off.It was reported that the patient had a blood transfusion, an extended hospitalization, and had a non-sudden cardiac death on (b)(6) 2022.
 
Manufacturer Narrative
This event has been reassessed and found not to be a reportable event.Adverse event was possibly due to procedure and not device related.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALLEYLAB FT10
Type of Device
ELECTROSURGICAL, CUTTING & COAGULATION & ACCES
Manufacturer (Section D)
COVIDIEN MFG DC BOULDER
5920 longbow dr
boulder CO 80301 3299
Manufacturer (Section G)
COVIDIEN MFG DC BOULDER
5920 longbow dr
boulder CO 80301 3299
Manufacturer Contact
justin ellis
8200 coral sea st ne
mounds view, MN 55112
7635265677
MDR Report Key15411430
MDR Text Key299781590
Report Number1717344-2022-01109
Device Sequence Number1
Product Code GEI
UDI-Device Identifier10884521516328
UDI-Public10884521516328
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K151649
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberVLFT10GEN
Device Catalogue NumberVLFT10GEN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/15/2022
Initial Date FDA Received09/13/2022
Supplement Dates Manufacturer Received09/14/2022
Supplement Dates FDA Received09/30/2022
Date Device Manufactured10/27/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
PLEASE SEE NOTE ON H10
Patient Outcome(s) Life Threatening; Death; Hospitalization; Required Intervention;
Patient Age69 YR
Patient SexFemale
Patient Weight81 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-